Literature DB >> 14869022

Operative cholangiography: an evaluation of 406 cases.

C G MIXTER, L HERMANSON, A L SEGEL.   

Abstract

Keywords:  BILE DUCTS/diseases; BILIARY TRACT/diseases

Mesh:

Year:  1951        PMID: 14869022      PMCID: PMC1802941          DOI: 10.1097/00000658-195109000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  11 in total

1.  Indications for the use of operative cholangiography.

Authors:  W E SULLENS; G A SEXTON
Journal:  Ann Surg       Date:  1955-04       Impact factor: 12.969

2.  Residual common duct calculi.

Authors:  A O SINGLETON; J L COLEMAN
Journal:  Ann Surg       Date:  1956-05       Impact factor: 12.969

3.  Operative cholangiography.

Authors:  A W NURICK
Journal:  Postgrad Med J       Date:  1956-08       Impact factor: 2.401

4.  Residual stones in the common bile duct: the question of operative cholangiograms.

Authors:  E V JOHNSTON; J M WAUGH; C A GOOD
Journal:  Ann Surg       Date:  1954-03       Impact factor: 12.969

5.  Fibrosis of the sphincter of Oddi.

Authors:  R B CATTELL; B P COLCOCK
Journal:  Ann Surg       Date:  1953-06       Impact factor: 12.969

6.  Operative cholangiography.

Authors:  E S HUGHES; R H KERNUTT
Journal:  Br Med J       Date:  1954-09-11

7.  Routine operative cholangiography: an evaluation.

Authors:  L I NIENHUIS
Journal:  Ann Surg       Date:  1961-12       Impact factor: 12.969

8.  Operative cholangiography: a case for its routine use.

Authors:  P C Jolly; J W Baker; H M Schmidt; J H Walker; J C Holm
Journal:  Ann Surg       Date:  1968-09       Impact factor: 12.969

9.  Operative cholangiography. Its effect on the practice of cholecystectomy.

Authors:  M H Wheeler; S Raksasook; J A Williams
Journal:  Br Med J       Date:  1970-10-17

10.  Intraoperative cholangiography. A review of indications and analysis of age-sex groups.

Authors:  S B Levine; H J Lerner; E D Leifer; S R Lindheim
Journal:  Ann Surg       Date:  1983-12       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.